Recruiting
Phase 1

Sponsor:

Merrimack Pharmaceuticals

Code:

NCT03076372

Conditions

Solid Tumors

Urothelial Carcinoma

Gastric Carcinoma

Squamous Cell Carcinoma of the Head and Neck

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MM-310

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-25. This information was provided to ClinicalTrials.gov by Merrimack Pharmaceuticals on 2018-02-27.